Skip to main content

Table 1 Demographics of the study population

From: Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation

Variables

Healthy subjects (n = 15)

DCM (n = 12)

ICM (n = 10)

P value

Age (years)

50.5 ± 6.5

49.3 ± 16.0

54.9 ± 7.3

0.475

Male (n, %)

13 (86.7)

11 (91.7)

9 (90.0)

1.000

Height (cm)

167.3 ± 4.4

167.4 ± 6.4

168.3 ± 4.6

0.889

Weight (kg)

68.5 ± 9.4

65.2 ± 18.8

66.5 ± 5.6

0.869

BMI (kg/m2)

24.4 ± 3.0

25.0 ± 3.7

23.1 ± 1.2

0.321

BSA (m2)

1.81 ± 0.14

1.77 ± 0.25

1.79 ± 0.07

0.967

Heart rate (bpm)

64 ± 7

83 ± 18*

75 ± 17

0.023

Haematocrit (%)

42.5 ± 3.8

41.9 ± 2.9

39.7 ± 6.6

0.675

Hypertension (n, %)

0 (0)

3 (25.0)

4 (40.0)

–

Diabetes mellitus (n, %)

0 (0)

4 (33.3)

4 (40.0)

–

Hyperlipidaemia (n, %)

0 (0)

1 (8.3)

2 (20.0)

–

Smoker (n, %)

6 (40.0)

4 (33.3)

7 (70.0)

0.263

Family history of coronary artery disease (n, %)

0 (0.0)

0 (0.0)

0 (0.0)

–

Duration (years)

–

6.5 ± 3.7

2.2 ± 1.5

–

Time between CMR and transplantation (days)

–

15 ± 11

27 ± 35

–

NYHA functional class III/IV (n, %)

–

2 (16.7)/10 (83.3)

1 (10.0)/9 (90.0)

–

NT-proBNP (pg/mL)

–

4680.9 ± 6064.7

3294.0 ± 3482.7

–

BUN (mmol/L)

–

8.6 ± 5.1

7.5 ± 3.0

–

Creatinine (μmol/L)

–

107.8 ± 51.5

125.8 ± 81.6

–

  1. Values are expressed as the mean ± SD or n (%)
  2. *p <  0.05 vs. controls
  3. DCM Dilated cardiomyopathy, ICM Ischaemic cardiomyopathy, BMI Body mass index, BSA Body surface area, CMR Cardiac magnetic resonance, NYHA New York Heart Association, NT-proBNP N-terminal pro-brain natriuretic peptide, BUN Blood urea nitrogen